SUMMARY Adenosine 3',5'-monophosphate (cyclic AMP), 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) 
SUMMARY Adenosine 3',5'-monophosphate (cyclic AMP), 5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) were determined in the cerebrospinal fluid of patients with respiratory disorder and hypersomnia and in control patients. Patients with the sleep apnoea syndrome confirmed polygraphically showed elevated levels of cyclic AMP and 5-HIAA. Cyclic AMP levels were inversely correlated with arterial Po2, measured under resting conditions. The level of HVA also was raised, but the change was not statistically significant.
Catecholamine and indoleamine neurotransmitters play a key role in the central regulation of sleep and vigilance. While Other evidence indicates that the neurotransmitters serotonin and dopamine control the synthesis of adenosine 3',5'-monophosphate (cyclic AMP) in the brain,7 8 and cerebral glucogenolysis in response to these hormones and to anoxia appears to be mediated by this cyclic nucleotide.9 10 Indirect evidence for an involvement of cyclic AMP in the regulation of sleep in the brain stem has been reviewed elsewhere." In this paper we report the results of a study of cerebrospinal fluid levels of cyclic AMP and of the monoamine metabolites HVA and 5-HIAA in patients with the sleep apnoea syndrome and respiratory disorders.
Patients and methods
Eight patients (seven males, one female, mean age 53 6 years) were studied for suspicion of the sleep apnoea syndrome. All presented with obesity and complaints of diurnal somnolence (table 1). The patients were subjected to complete tests of cardiorespiratory functions including blood gas analysis in the resting condition, all-night polygraphic recording of EEG, EMG, eye movements and respiration, and lumbar puncture with analysis of CSF, in addition to thorough neurological examination, radiography of the skull and routine laboratory examinations.
Seven patients (five males, two females, mean age 39 4 ± 52 years) who consulted for lumbago and suspicion of vertebral disc herniation served as controls. All patients were free of central nervous system disease. Routine CSF values (protein content, cell count) were normal. Lumbar punctures were performed in the decubitus position. Eight ml of CSF were removed, aliquots were immediately frozen and stored at -40°C until analysis. Cyclic Cramer, Warter, Renaud, Krieger, Marescaux, Hammers Cyclic AMP anid neurotratismitter metabolites in CSF system disease. Within the group of sleep apnoea patients there was a correlation between the levels of cyclic AMP and P02 (r = -086, p < 0 05). Further, a correlation was found between 5-HIAA and Po2 (r = -0-86, p < 0-05). No correlation was apparent between HVA and the values of blood gas analysis.
Discussion
Cyclic AMP levels in CSF are elevated in patients with sleep apnoea syndrome. Moreover, the cyclic AMP levels are positively correlated to the degree of hypoxia and of hypercapnia in our patients. This finding is not specific for the sleep apnoea syndrome, but is a reflection of the metabolic disturbance induced by hypoxia, for we also found an increased level of cyclic AMP in a patient with polycythaemia, as a result of chronic hypoxia due to primary respiratory disease. Increased cyclic AMP levels in the CSF appear to be a useful indicator of central hypoxia, as has been shown also in animal experiments.14 Evidence for locally increased cyclic AMP metabolism was also reported in patients with cerebral infarction.15
The observation of increased levels of 5-HIAA in the sleep apnoea syndrome confirms earlier preliminary reports.5 6 Normal levels of 5-HIAA were found in the small group of patients with respiratory disease and diurnal somnolence but undisturbed sleep. In contrast to Baruzzi's observation6 in only two cases, our patients showed a statistically insignificant elevated mean level of HVA; marked increases in some patients were not correlated with any of the other metabolic parameters tested.
Our findings suggest that serotonergic systems and cyclic AMP as a second messenger are involved in the sleep apnoea syndrome. Apparently, neither the serotonin metabolite nor cyclic AMP is altered in other syndromes with hypersomnia such as narcolepsy and the subwakefulness syndrome (Cramer et al, unpublished observation) . While cyclic AMP levels may reflect cerebral hypoxia, the disturbance of serotonin metabolism may be more specifically connected to the sleep disorder in the sleep apnoea syndrome. Under severe cerebral ischaemia, brain levels of serotonin were decreased. 
